Here we are at the BHI after a day of ripping out tile and installing shoe molding: And heres an article about us from The Vermont Standard that we thought you might enjoy. Peter Kolchinsky is a biotechnology investor and a scientist. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. This investment adviser does not provide advice to individual investors. He served on the Board of Global Science and Technology for the National Academy of Sciences from 2009 to 2012, is the author of "The Great American Drug Deal" and "The Entrepreneurs Guide to a Biotech Startup", and frequently writes and speaks on the future of biotechnology innovation. and bought an estimated value of $64.19M worth of shares. $5M . The gurus listed in this website are not affiliated with GuruFocus.com, LLC. He co-founded and runs the Boston-based investment firm RA Capital Management; writes and teaches about biomedical entrepreneurship and its potential to transform global health; serves on the boards of several public and private drug development companies; and lives in Massachusetts with his historian/equestrian wife, strong-willed children, and How do you see re-infections? The current estimated net worth of Mineralys Therapeutics, Inc's Director, Peter Kolchinsky, is estimated to be about $2.7B . In the interim, they plan to invite local folks in to see the changes, try out some wines, and make new friends. Refer a Friend and Earn One Month of Free Membership. Peter Kolchinsky is a founder, Portfolio Manager, and Managing Director at RA Capital Management, LLC, a multi-stage investment manager dedicated to evidence-based investing in healthcare and. He studied philosophy at Oregon State University and then earned a law degree from the University of Oklahoma. Dyne Therapeutics, Inc's most recent insider trade came on January 23, 2023 by Recently at Dyne Therapeutics, Inc, Peter Kolchinsky has sold an estimated value of $0 worth. Ignoring warning calls from pharma companies and the Association of the British Pharmaceutical Industry (ABPI), the UK government announced its planning to raise the revenue clawback rate paid by pharmaceutical companies on the Statutory Scheme for Branded Medicines from 24.4% to 27.5%. December 22nd, 2014. . Peter Kolchinsky is a founder and Managing Partner at RA Capital Management and author of The Great American Drug Deal. Insider trading is most common in June, with the busiest year in 2022. Solid Biosciences Inc's most recent insider trade came on January 31, 2023 by Covid-19. In this conversation. The fund was seeded by Vertex Pharma co-founder Rich Aldrich, who invested $4 million at . The role of insurance and the value of what should be a celebrated national resource - the growing mountain of generic drugs - are overlooked and yet form the foundation of a workable solution.The Great American Drug Deal examines the healthcare landscape through the lens of this contract, including the government's role in inventing drugs, direct-to-consumer advertising, the opioid crisis, the price-jacking of old drugs, and the impact on America of lower drug costs in other countries. The two announced Monday morning that theyve put together their first pure-play venture fund at RA Capital Management, which has been known to bet on just about every angle in healthcare investing from rounds to follow-on investments at public companies. In this conversation. A hike is also under consideration for the voluntary scheme. Peter Kolchinsky is the Director, 10% Owner of Synthorx Inc and owns about 14,903,741 shares of Synthorx Inc (THOR) stock worth over $1.0 Billion . The name for the inn was Annas inspiration; The Blue Horse Inn speaks both to her German heritage and her love of art and horses. In . May 5, 2003 Like all mothers, Evelina Kolchinsky wanted her son, Peter, to adjust to school and do well. He currently manages a fund that invests in healthcare and biotechnology companies. Opinion. Everyone has been so generous with us, sharing advice and stories. magic link that lets you log in quickly without using a password. Gurus may be added or dropped from the GuruFocus site at any time. There are 15 older and 2 younger executives at Wave Life Sciences. The current estimated net worth of Solid Biosciences Inc's Director, Peter Kolchinsky, is estimated to be about $2.89B . It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. Peter Kolchinsky: We need to see the difference between a true re-infection. Peter Kolchinsky graduated from Harvard with a Ph.D. in virology in 2001. Current Endpoints readerscan visit their reader profileto add Endpoints Weekly. Both Moffitt Cancer Center and Mayo Clinic in Florida, not too far from Domingos and his family, said he would have to wait between three and a half and four months to get the treatment. worked in film production in Berlin for several years before returning to Boston, where she met Peter. The most active traders at the company are The information on this site is in no way guaranteed for completeness, accuracy or in any other way. Most importantly, this book describes concrete, actionable reforms under which patients will be able to afford their treatments and society will continue to reap the benefits of medical innovation. By India Today Web Desk: With more than 22 lakh people infected, more than 1.5 lakh dead of the novel coronavirus, health experts all over the world are scrambling to understand just how did this one virus get so potent.. Boston, MA. Peter Kolchinsky Net Worth The estimated Net Worth of Peter Kolchinsky is at least Wave Life Sciences stock worth over $36,046,604 and over the last 8 years he sold WVE stock worth over $58,095,632. RA Capital is a multi-stage investment manager dedicated to evidence-based investing in public and private healthcare and life science companies that are . The singer-songwriter and actress is the latest celebrity addition to Merz Aesthetics Beauty on Your Terms campaign for Botox rival Xeomin. (LogOut/ The estimated net worth of Peter Kolchinsky is at least $1.2 Billion dollars as of 2023-02-17. The Kolchinskys came. In total, Peter Kolchinsky has made about 2 transactions recently at Mineralys Therapeutics, Inc. Jonathan McNeill who sold, In the last 16 years, insiders at Dyne Therapeutics, Inc have sold an estimated value of, https://www.sec.gov/Archives/edgar/data/1818794/000119312521116286/d937458ddef14a.htm, Mailing address is 200 Berkeley Street 18th Floor Boston MA 02116 MA. Ben, a storyteller and football aficionado, looks forward to evenings of camaraderie with locals and inn guests. This slide deck contains a powerful visual illustration of the biotech industry's race to find a cure for Hepatitis C. Run through the slide deck quickly to appreciate the sheer level of hustle that won the world a cure, and then more slowly to appreciate every move in the chess game of mergers & acquisitions. Peter Kolchinsky's largest purchase order was, In total, Peter Kolchinsky has made about, Solid Biosciences Inc's most recent insider trade came on January 31, 2023 by Dr. Kolchinsky's firm held 7.3 million Ascendis Pharma A/S (NASDAQ:ASND) shares in Q3, which were worth $1.17 billion and made up for 16.31% of its portfolio. Bens wife, Keri, grew up on a red dirt road in small-town Georgia. Let us know if you like it and we may post more pieces with this option.) He co-founded and runs the Boston-based investment firm RA Capital Management, writes and teaches about biomedical entrepreneurship and its potential to transform global health, serves on the boards of several public and private drug development companies, and has served on the Board of Global Science and Technology for the National . Carl Ashley Morris, Chief Scientific Officer, So they invited their close friends Keri and Ben up for what they, Keri and Ben, long-time city dwellers, were, new dream and a substantial life-style change, One of my favorite paintings is from the Blue Horses, , and, of course, horses were what brought the couple to Woodstock. Franklin Resources Inc, Most recently he bought 6,337,135 units of KALA stock worth $49,999,995 on 13 March 2020 . As of 23 June 2020 he still owns at least 9,011,651 units of Wave Life Sciences stock. Past performance is a poor indicator of future performance. We loved the idea of having a second home that was also an inn, but we figured our friends and family would try to talk us out of it, said Anna. His wife, Nora Flor, said she and her sister made calls to at least 30 centers across the US looking for the drug. Its certain to be a challenging one! The most active traders at the company are Peter Kolchinsky / Published in City Journal / February 24, 2020 "Some health economists, such as those at the Institute for Clinical and Economic Review (ICER), believe that they can tell us the right price to pay for each new medicine that the FDA approves. Dr. Kolchinsky also leads RA Capitals engagement and publishing efforts, which aim to make a positive social impact and spark collaboration among healthcare stakeholders, including patients, physicians, researchers, policymakers, and industry. These . We'll e-mail you a link to set a new password. In total, Peter Kolchinsky has made about 1 transaction recently at Dyne Therapeutics, Inc. I am on Oahu until Friday, so please feel free to also contact me directly in order to discuss If you are considering starting your own biotech company, you will appreciate the wealth of practical information packed into The Entrepreneur's Guide to a Biotech Startup. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. A quarters-long flurry of layoffs has caused thousands of workers in life sciences to go hunting for their next position sooner than expected, and the latest wave could make it more difficult to get new offers in hand in short order. There are also venture partner and executive-in-residence programs to build up the bench. Peter Kolchinsky usually trades in December, with the busiest year in 2022. Peter Kolchinsky usually trades in September, with the busiest year in 2020. He holds a BA from Cornell University and a PhD in Virology from Harvard University. https://t.co/y9IG2Z5txl" Below is a lightly edited and condensed version of the interview. Fundamental company data provided by Morningstar, updated daily. These two energetic couples are living their dream with energy, imagination, creativity and a whole lot of. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. 2001 - Present22 years. Peter Kolchinsky - Insider Trading Tracker . Enjoy a 7-Day Free Trial Thru Mar 12, 2023! Keri is also a writer and is currently working on a Southern gothic novel. Anna is excited about introducing her dressage horse Jurist to the local network of trails. Anna Kolchinsky was born on 03/30/1979 and is 43 years old. One hopeful voice is biotech investor Peter Kolchinsky, the founder of RA Capital Management. Please note GuruFocus will not track the insiders transaction performance if he/she does not have buying transactions. Dr. Kolchinksy's hedge fund held 9.7 million Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) shares by the end of Q3 of 2021. (LogOut/ They will be in plain English and use colorful analogies." In addition, he makes $151,598 as Independent Director at Wave Life Sciences. He is active in both public and private investments in companies developing drugs, medical devices, diagnostics and research tools and serves as a board member for various public and privately-held . . and Ian F Smith, Director Endpoints News connected with the new chair of the generic industrys Association for Accessible Medicines, Christine Baeder, who is also Tevas COO, via video conference on Friday. The current estimated net worth of Dyne Therapeutics, Inc's Peter Kolchinsky is estimated to be about $2.88B . He currently works with the State and Local Government Practice Group of the consulting firm Accenture. Peter's mailing address filed with the SEC is C/O RA CAPITAL MANAGEMENT, L.P., 200 BERKELEY STREET, 18TH FLOOR, BOSTON, MA, 02116. Hedge Fund Net Worth $4.93B Peter Kolchinsky manages more assets than 43% of other Hedge Fund Managers Average Return +0.32% Since Last Filing Last 12 Months 3 Years (Annualized) Portfolio Breakdown by Sector Portfolio Breakdown 97.31% Healthcare 1.12% Services 0.78% Technology 0.51% Financial RA Capital Management Portfolio Activity Company Name The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. The real solution to affordability is hidden in plain sight amidst all the rhetoric about drug prices. $12.54M on September 23, 2020. This free 100-page eBook is based on personal interviews with entrepreneurs, investors, attorneys, and other professionals . Other family members and associates include Alexander Kolchinsky, Evelina Kolchinsky, Anna Kolchinsky, Joseph Kolchinsky and Joseph Kolchinsky. Dr. Kolchinsky earned his Ph.D. in virology from Harvard University and earned his bachelors degree in Biology from Cornell University. Hard work has helped him rise to the top. Peter Kolchinsky overall profits are growing on a daily basis, and he is becoming more popular on the sidelines. These two energetic couples are living their dream with energy, imagination, creativity and a whole lot of savvy business sense. Executives behind AI and precision medicine startup Tempus are putting together another AI outfit in Chicago focused on oncology drug discovery and development. Verified account Protected Tweets @ Protected Tweets @ Fundamental company data provided by Morningstar, updated daily. Robert Flexon, President and CEO, Save my name, email, and website in this browser for the next time I comment. Refer a Friend and Earn One Month of Free Membership. There are 12 executives at Wave Life Sciences getting paid more, with PaulBolno having the highest compensation of $3,581,530. Your email address will not be published. Anna and Peter originally hoped to find a vacation home that was big enough to share with friends and family and looked at the inn more out of curiosity than with any real intention to purchase it. Currently GuruFocus does not have mailing address information for Kolchinsky Peter. Let us know who we should consider our main ask is that you make the nominations personal. venue for exploring their particular passions. Hbm Healthcare Investments Cayman Ltd who bought 3,218,106 units worth Health Care. In the years Mineralys Therapeutics, Inc was active, insiders at Mineralys Therapeutics, Inc have bought an estimated value of $0 worth of shares. You can see the complete history of Peter Kolchinsky stock trades at the bottom of the page. Peter Kolchinsky's largest purchase order was 2,206,685 units , worth over and Catherine James, EVP and General Counsel Peter Kolchinsky owns about 10,916,567 units of Solid. Wave aspires to develop best-in-class medicines across multiple therapeutic modalities using PRISM, the company's proprietary discovery and drug development platform that enables the precise design, optimization and production of stereopure oligonucleotides. Source: https://www.sec.gov/Archives/edgar/data/1818794/000119312521116286/d937458ddef14a.htm. we figured our friends and family would try to talk us out of it, said Anna. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. CB Rank (Investor) 53,342 Primary Job Title Portfolio Manager and Managing Director Primary Organization RA Capital Management Location Boston, Massachusetts, United States Regions Greater Boston Area, East Coast, New England Gender Male Investor Type Investment Partner LinkedIn View on LinkedIn . Forbes and business insiders have done a recent study and say that Peter Kolchinsky net worth is more than a couple of million dollars. I am on Oahu until Friday, so please feel free to also contact me directly in order to discuss She received a Masters degree in TV production at Boston University and worked in film production in Berlin for several years before returning to Boston, where she met Peter. The outspoken and occasionally caustic Kolchinsky is partnered with an urbane and widely-liked Shah. The Great American Drug Deal examines the healthcare landscape through the lens of this contract, including the government's role in inventing drugs, direct-to-consumer advertising, the opioid crisis, the price-jacking of old drugs, and the impact on America of lower drug costs in other countries. Bens got me beat so far by three perch and a bass and Im trying to catch up. Peter Kolchinsky. At least three dozen biotechs let employees go so far this year, based on Endpoints News reporting, with more having done so under the radar. Please note this link is one-time use only and is valid for only 24 hours. Peter Kolchinsky owns over 4,000,000 units of Wave Life Sciences stock worth over $37,758,818 and over the last 9 years he sold WVE stock worth over $58,095,632. Required fields are marked *. Peters wife, Anna, grew up in Germany, Austria, and France, and came to Boston to attend Wellesley College. Thus, plans for a second home for two quickly gave way to a new dream and a substantial life-style change for four. out how to maintain the house themselves, from the roof to the, Anna and Keri hope their husbands dont electroc, can be found busily working at The Blue Horse Inn most weekends. Quality, Value, Ownership Undervalued - Ebit/EV + B/M Blend Quality, Value, Momentum Activist Targets Dividend Yield Microcap with Revenue NCAV Screen Net Net Working Capital Negative Enterprise Value Piotroski Score ROIC Screen Short Volume Ratio High Insider Selling High Insider Buying In addition, he makes $151,598 as Independent Director at Wave Life Sciences. one-time use only and expires after 24 hours. hope that what we do with the inn will come to reflect the spirit of this wonderful community. Anna is ex, cited about introducing her dressage horse, Im looking forward to some fishing. Many proposed solutions, including drug price controls, threaten to defund innovation but also distract the public from the real problem, which lies in the unraveling of the biotech social contract the implicit agreement between the biopharmaceutical industry and American society. Come and visit me at the Pacific Water Conference, booth 520! The malignant cells permeated his bones, kidney, lungs and liver, and in December, his oncologist told him there was no point in continuing chemotherapy treatment.